Balyasny Asset Management »

Biogen Idec shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2012-12-31 $454k 3.1k 146.45
2012-03-31 $3.8M 31k 126.00

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Mastercard Incorporated Cl A Call Option (MA)
Hess Call Option (HES)
Lockheed Martin Corporation Call Option (LMT)
Endeavor Group Hldgs Cl A Com Put Option (EDR)

View all positions for Balyasny Asset Management

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
BlackRock
State Street Corporation
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Geode Capital Management
T. Rowe Price Associates
Beutel, Goodman & Company
Invesco
Morgan Stanley
Goldman Sachs Group
Northern Trust
RA Capital Management

View all funds holding Biogen Idec